Retina
Showing 1 - 25 of 2,729
Retinopathy of Prematurity Trial (Diode laser photocoagulation.)
Not yet recruiting
- Retinopathy of Prematurity
- Diode laser photocoagulation.
- (no location specified)
Sep 16, 2023
Non-Proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (Faricimab)
Not yet recruiting
- Non-Proliferative Diabetic Retinopathy
-
Bakersfield, California
- +18 more
Jan 25, 2023
Neovascular Age-related Macular Degeneration Trial in United States (SUSVIMO (ranibizumab injection), LUCENTIS (ranibizumab
Recruiting
- Neovascular Age-related Macular Degeneration
- SUSVIMO (ranibizumab injection)
- LUCENTIS (ranibizumab injection)
-
Mesa, Arizona
- +32 more
Jan 13, 2023
Macular Degeneration, Age-Related, Geographic Atrophy Trial in United States (FHTR2163)
Terminated
- Macular Degeneration, Age-Related
- Geographic Atrophy
-
Bakersfield, California
- +51 more
Nov 22, 2022
Diabetic Macular Edema Trial in United States (intravitreous aflibercept, Bevacizumab + Deferred Aflibercept Group)
Completed
- Diabetic Macular Edema
- intravitreous aflibercept
- Bevacizumab + Deferred Aflibercept Group
-
Campbell, California
- +53 more
Nov 28, 2022
Electronic Cigarette Use, Retina; Change Trial in Montréal (RETI-port/scan 21, Zilia Ocular, OCT-A)
Recruiting
- Electronic Cigarette Use
- Retina; Change
- RETI-port/scan 21
- +2 more
-
Montréal, Quebec, CanadaÉcole d'optométrie de l'Université de Montréal
Apr 3, 2023
Diabetic Macular Edema (DME) Trial in Worldwide (KHK4951, Aflibercept Injection)
Not yet recruiting
- Diabetic Macular Edema (DME)
- KHK4951
- Aflibercept Injection
-
Arcadia, California
- +29 more
Oct 31, 2023
RETINA-AI Galaxy™ v2.0,Automated Diabetic Retinopathy Screening
Not yet recruiting
- Diabetes
- +3 more
- Color fundus photograph
- +2 more
- (no location specified)
Oct 25, 2022
Perfluorooctyl Bromide Which Empowers Liquid to Flat Detached
Recruiting
- Retinal Disease
-
Cairo, Kubri EL Kubba, EgyptGirgis Boules
Jan 24, 2023
Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma Trial in United States (Belzupacap Sarotalocan, Suprachoroidal
Recruiting
- Choroidal Melanoma
- +3 more
- Belzupacap Sarotalocan
- +5 more
-
Birmingham, Alabama
- +32 more
Aug 23, 2023
Non-proliferative Diabetic Retinopathy Trial in United States (OPL-0401 Dose 1, OPL-0401 Dose 2, Placebo)
Recruiting
- Non-proliferative Diabetic Retinopathy
- OPL-0401 Dose 1
- +2 more
-
Mountain View, California
- +20 more
Dec 16, 2022
Dry Age-related Macular Degeneration Trial in Worldwide (GT005: Medium Dose, GT005: High Dose)
Active, not recruiting
- Dry Age-related Macular Degeneration
- GT005: Medium Dose
- GT005: High Dose
-
Phoenix, Arizona
- +61 more
Dec 14, 2022
Pain, Intravitreal Injection, Pain, Acute Trial in Canada, United States (Use of bromfenac 0.09% to reduce intravitreal
Recruiting
- Pain
- +2 more
- Use of bromfenac 0.09% to reduce intravitreal injection pain
- Use of artificial tears to reduce intravitreal injection pain
-
Boston, Massachusetts
- +4 more
Nov 8, 2023
Geographic Atrophy of the Macula, Macular Degeneration Trial in United States (AVD-104, Sham injection)
Not yet recruiting
- Geographic Atrophy of the Macula
- Macular Degeneration
- AVD-104
- Sham injection
-
Saint Petersburg, Florida
- +4 more
Apr 20, 2023
Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study
Active, not recruiting
- Neovascular Age-related Macular Degeneration
-
Phoenix, Arizona
- +6 more
Dec 14, 2022
Epiretinal Membrane Trial in United States (Immediate Vitrectomy, Deferred Vitrectomy)
Recruiting
- Epiretinal Membrane
- Immediate Vitrectomy
- Deferred Vitrectomy
-
Glendale, California
- +18 more
Aug 15, 2022
Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)
Active, not recruiting
- Non-proliferative Diabetic Retinopathy
- KSI-301
- Sham injection
-
Phoenix, Arizona
- +46 more
Sep 22, 2022
Diabetic Retinopathy Trial in Puerto Rico, United States (PDS Implant Pre-Filled with 100 mg/mL Ranibizumab, Intravitreal
Active, not recruiting
- Diabetic Retinopathy
- PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
- Intravitreal Ranibizumab 0.5 mg Injection
-
Dothan, Alabama
- +75 more
Aug 3, 2022
Vitreomacular Traction Trial in United States (Pneumatic Vitreolysis (C3F8 injection), Observation)
Completed
- Vitreomacular Traction
- Pneumatic Vitreolysis (C3F8 injection)
- Observation
-
Campbell, California
- +40 more
Sep 6, 2022
Neovascular Age-related Macular Degeneration Trial in United States (AM712(ASKG712))
Recruiting
- Neovascular Age-related Macular Degeneration
- AM712(ASKG712)
-
Poway, California
- +8 more
Aug 9, 2022